首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1630740

疼痛管理治疗市场规模、份额、成长分析（按药物类别、适应症、分销管道和地区划分）- 产业预测，2025 年至 2032 年

Pain Management Therapeutics Market Size, Share, Growth Analysis, By Drug Class (NSAIDs, Anesthetics), By Indication (Arthritic Pain, Neuropathic Pain), By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月09日 | 出版商:

SkyQuest | 英文 276 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球疼痛管理治疗市场规模价值为 787 亿美元，预计将从 2024 年的 815.3 亿美元成长到 2032 年的 1,082 亿美元，预测期内（2025-2032 年）的复合年增长率为 3.6%。

截至 2023 年 10 月，疼痛管理领域反映出人们越来越认识到其在医学领域的重要性。越来越多的医生开始求助于疼痛医学专家来实施多学科方法来改善患者多种疼痛的生活质量，包括纤维肌痛、神经病变疼痛和术后不适等慢性病。疼痛管理治疗越来越受欢迎，因为它们可以解决广泛的医疗问题。然而，由于政府预算削减和药品赞助商支持减少，疼痛倡导团体的影响力和财力资源减少，市场也面临挑战。由于这些组织历来在推动疼痛管理倡议方面发挥关键作用，因此这一趋势对市场成长构成了潜在的障碍。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

CSL Behring（Australia）
Takeda Pharmaceutical Company Limited（Japan）
Pharming Group NV（Netherlands）
BioCryst Pharmaceuticals, Inc.（USA）
Ionis Pharmaceuticals, Inc.（USA）
Sanofi SA（France）
Adverum Biotechnologies, Inc.（USA）
KalVista Pharmaceuticals, Inc.（USA）
Attune Pharmaceuticals, Inc.（USA）
Arrowhead Pharmaceuticals, Inc.（USA）
Amgen Inc.（USA）
BioMarin Pharmaceutical Inc.（USA）
Catalyst Biosciences, Inc.（USA）
RUCONEST（Pharming Group NV, Netherlands）
Haegarda（CSL Limited, Australia）
Firazyr（Shire plc, UK）
Shire plc（UK）
Dyax Corp.（USA）
Adverum Biotechnologies, Inc.（USA）
Amgen Inc.（USA）

结论和建议

简介目录

Product Code: SQMIG35F2004

Global Pain Management Therapeutics Market size was valued at USD 78.7 billion in 2023 and is poised to grow from USD 81.53 billion in 2024 to USD 108.2 billion by 2032, growing at a CAGR of 3.6% during the forecast period (2025-2032).

As of October 2023, the landscape of pain management reflects a growing recognition of its importance within the medical field. Physicians increasingly turn to pain medicine specialists to implement multidisciplinary approaches that enhance patient quality of life across various types of pain, including chronic conditions like fibromyalgia, neuropathic pain, and post-operative discomfort. The rising popularity of pain management therapeutics is evident as they cater to a wide spectrum of medical issues. However, the market faces challenges as pain advocacy organizations experience diminishing influence and financial resources due to government funding cuts and decreased support from pharmaceutical sponsors. This trend poses a potential hurdle for market growth as these organizations have historically played a crucial role in advancing pain management initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pain Management Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pain Management Therapeutics Market Segmental Analysis

Global Pain Management Therapeutics Market is segmented by Drug Class, Indication, Distribution channel and region. Based on Drug Class, the market is segmented into NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics and Others. Based on Indication, the market is segmented into Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis and Others. Based on Distribution channel, the market is segmented into Online Pharmacy, Hospital Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pain Management Therapeutics Market

The global pain management therapeutics market is experiencing significant growth due to the increasing prevalence of various medical conditions that lead to pain and discomfort, such as ulcers, osteoarthritis, chronic arthritis, multiple sclerosis, cancer, and diabetic neuropathy. These conditions necessitate effective treatments for both acute and chronic pain, driving demand for pain management solutions. As patients seek relief from their ailments, the preference for advanced pain management therapeutics rises, further fueling market expansion. Consequently, the collective urgency to address pain-related issues across diverse populations is a crucial factor contributing to the market's robust development.

Restraints in the Global Pain Management Therapeutics Market

The growth of the Global Pain Management Therapeutics market is anticipated to be hindered by the issue of prescription drug abuse. Many individuals consume prescribed medications in a manner that deviates from medical guidance, often underestimating the potential dangers associated with such behavior. This misuse not only poses significant health risks but can also result in severe consequences, including fatal outcomes. As awareness of these dangers increases, it may lead to stricter regulations and more cautious prescribing practices, ultimately curbing the expansion of the market. Consequently, addressing the challenges posed by prescription misuse is crucial for sustainable market growth.

Market Trends of the Global Pain Management Therapeutics Market

The Global Pain Management Therapeutics market is witnessing a significant trend towards personalized medicine, with a growing focus on biologics and rapid-acting lifestyle therapies, which currently represent over 70% of all medications under development. This shift is driven by advancements in pharmacogenomics and an increased understanding of individual pain mechanisms, leading to targeted treatments that enhance efficacy and reduce side effects. Additionally, the rising prevalence of chronic pain conditions and a growing aging population are fueling demand for innovative therapies, positioning personalized approaches as a key driver in the evolution of pain management strategies globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Patent Analysis

Global Pain Management Therapeutics Market Size by Drug Class & CAGR (2025-2032)

Market Overview
NSAIDs
Anesthetics
Anticonvulsants
Anti-migraine Agents
Antidepressants
Opioids
Nonnarcotic Analgesics
Others

Global Pain Management Therapeutics Market Size by Indication & CAGR (2025-2032)

Market Overview
Arthritic Pain
Neuropathic Pain
Cancer Pain
Chronic Back Pain
Postoperative Pain
Migraine
Fibromyalgia
Muscle Sprain/Strain
Bone Fracture
Acute Appendicitis
Others

Global Pain Management Therapeutics Market Size by Distribution channel & CAGR (2025-2032)

Market Overview
Online Pharmacy
Hospital Pharmacy
Retail Pharmacy

Global Pain Management Therapeutics Market Size & CAGR (2025-2032)

North America (Drug Class, Indication, Distribution channel)
- US
- Canada
Europe (Drug Class, Indication, Distribution channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Drug Class, Indication, Distribution channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Drug Class, Indication, Distribution channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Drug Class, Indication, Distribution channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharming Group N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCryst Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ionis Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adverum Biotechnologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KalVista Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Attune Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrowhead Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMarin Pharmaceutical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalyst Biosciences, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RUCONEST (Pharming Group N.V., Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haegarda (CSL Limited, Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Firazyr (Shire plc, UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shire plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dyax Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adverum Biotechnologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments